InterCure Ltd. (NASDAQ:INCR – Get Free Report) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 16,200 shares, an increase of 16.5% from the October 31st total of 13,900 shares. Based on an average trading volume of 32,200 shares, the short-interest ratio is currently 0.5 days. Currently, 0.1% of the company’s stock are short sold.
InterCure Trading Down 1.5 %
INCR traded down $0.02 on Friday, hitting $1.33. The company had a trading volume of 12,514 shares, compared to its average volume of 54,748. InterCure has a 1-year low of $1.17 and a 1-year high of $3.72. The company has a quick ratio of 1.15, a current ratio of 1.78 and a debt-to-equity ratio of 0.15. The company’s fifty day moving average price is $1.65 and its 200 day moving average price is $2.08.
Institutional Investors Weigh In On InterCure
Several hedge funds have recently modified their holdings of INCR. Virtu Financial LLC acquired a new position in InterCure during the 3rd quarter valued at $43,000. Jane Street Group LLC bought a new position in shares of InterCure during the 3rd quarter worth about $49,000. Renaissance Technologies LLC raised its position in shares of InterCure by 30.9% during the second quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after buying an additional 10,700 shares during the last quarter. AdvisorShares Investments LLC bought a new stake in shares of InterCure in the second quarter valued at about $218,000. Finally, Tidal Investments LLC acquired a new stake in InterCure during the first quarter worth about $883,000. 8.34% of the stock is owned by institutional investors.
About InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
See Also
- Five stocks we like better than InterCure
- Best Stocks Under $5.00
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Stock Market Sectors: What Are They and How Many Are There?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Using the MarketBeat Dividend Yield Calculator
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.